Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

AC Immune (ACIU) Debt to Equity (2017 - 2020)

AC Immune has reported Debt to Equity over the past 4 years, most recently at $0.0 for Q3 2020.

  • Quarterly Debt to Equity fell 38.41% to $0.0 in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $0.0 through Sep 2020, down 38.41% year-over-year, with the annual reading at $0.0 for FY2019, 17.94% down from the prior year.
  • Debt to Equity was $0.0 for Q3 2020 at AC Immune, up from $0.0 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.0 in Q4 2017 and troughed at $0.0 in Q1 2020.
  • The 4-year median for Debt to Equity is $0.0 (2019), against an average of $0.0.
  • Year-over-year, Debt to Equity decreased 17.94% in 2019 and then plummeted 47.41% in 2020.
  • A 4-year view of Debt to Equity shows it stood at $0.0 in 2017, then tumbled by 31.03% to $0.0 in 2018, then decreased by 17.94% to $0.0 in 2019, then tumbled by 44.46% to $0.0 in 2020.
  • Per Business Quant, the three most recent readings for ACIU's Debt to Equity are $0.0 (Q3 2020), $0.0 (Q2 2020), and $0.0 (Q1 2020).